hD
$
13.73
7.10%
-$1.05
As of October 16, 2026
· USD
Open
$14.73
High
$15.17
Low
$12.98
Prev Close
$14.78
Volume
977,900
52-Wk High
$28
52-Wk Low
$12.94
Market Cap
$626.79M
P/E
-5.01
EPS
$-2.74
About
A clinical-stage biopharmaceutical company developing biotherapeutics for immune-mediated diseases using its ATTOBODY biologics platform. The company's lead candidate, ATTO-1310, targets interleukin-31 (IL-31), known as ...See more
Ticker
ATTO
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CEO
Tao Fu
Website
https://www.attovia.com ↗
Address
1091 Industrial Rd, Ste 310, San Carlos, CA, 94070, US
Market Cap
$626.79M
Financial Performance
| Net sales | |||||
| Gross margin | |||||
| Net income |
In the news